Search Terms

We have searched all clinical trials databases with four terms:

aspergillosis
aspergilloma
aspergillus
abpa

Results were cross checked for duplication and then entered into this database.

Databases searched are all listed on this page at Current Controlled Trials.com

Current Trials

Recruiting
Phase Title
IV Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene).
III Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
III Isavuconazole in the Treatment of Aspergillosis and Rare Fungi
II Micafungin Salvage Mono-Therapy in Invasive Aspergillosis
Interventional Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
II Prophylaxis of Fungal Invasive Infections in Leukemia (PROFIL-C)
II Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)
III Isavuconazole for Primary Treatment of Invasive Aspergillosis
Observational Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
II Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
IV Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
III To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early
Observational Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
II Prophylaxis With Caspofungin in High-Risk Liver Transplantation
III Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
Observational Fungal allergy and domestic exposure to fungi in cystic fibrosis (Australian Cystic Fibrosis Research Trust 2004/052)
IV Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
Not Recorded A trial looking at 2 new tests to diagnose a fungal infection
III Phase III Doubleblind, Comparative Study of MK0991 (Caspofungin) in Japanese Patients
   
Active not yet recruiting
Phase Title
Interventional Prophylactic Azithromycin for Bronchiectasis, a randomised controlled trial to assess whether azithromycin reduces exacerbation frequency, improves health-related quality of life and increases lung function.
III Phase III Doubleblind, Comparative Study of MK0991 (Caspofungin) in Japanese Patients
   
Active not recruiting
Phase Title
III Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
Interventional A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients
I, II Pilot Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer (MUTT_Pilot)
Not Recorded Early Diagnosis of Invasive Aspergillosis
   
Enrolling by invitation
Phase Title
Observational Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations
   
Withdrawn
Phase Title
IV A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
   
Terminated
Phase Title
II Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
IV Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
Observational An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
   
Completed
Phase Title
III Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
II, III A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).
IV COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis
II MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis
II Study of FK463 for the Treatment of Invasive Aspergillosis
III Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment
IV Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
II Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
III An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
I Voriconazole to Prevent Systemic Fungal Infections in Children
III Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients
IV A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
II Documented Candida or Aspergillus Infections in Pediatric Patients Results of trial
II A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
III Voriconazole to Treat Fungal Infections
Observational Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)(COMPLETED)
II Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
I Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
III Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)(COMPLETED)
III Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) (COMPLETED)
II PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)(COMPLETED)
Interventional A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
III Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
III An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
Interventional Randomised, placebo controlled trial of itraconazole in the treatment of fungal sensitised patients with severe asthma and without allergic bronchopulmonary aspergillosis (ABPA)
Interventional A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
Observational A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
III Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
Interventional? Treatment of chronic endobronchial Aspergillus infection with voriconazole in patients with Cystic fibrosis.
Not Given Voriconazole study: treatment of chronic endobronchial Aspergillus infection with voriconazole in patients with cystic fibrosis
III Data Review Committee Procedures and Analysis for the Comparison of Data From P00041 and P02387 Results of trial
   
 
Search all Clinical Trials
 
Search by Title, Location, Identifier or Keyword: